FDA label
What is ivermectin used for?
The FDA-approved uses of ivermectin, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Ivermectin tablets, USP are indicated for the treatment of the following infections:”
Run it in Rivvi
Which 2027 plans near you dropped or restricted ivermectin?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ivermectin, tablet
Indications and Usage, quoted from the label by Ajanta Pharma USA Inc. (ANDA218509). Cross-references to other label sections are left out.
Ivermectin tablets, USP are indicated for the treatment of the following infections:
Strongyloidiasis of the intestinal tract. Ivermectin tablets are indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis.
This indication is based on clinical studies of both comparative and open-label designs, in which 64% to 100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin. (See CLINICAL PHARMACOLOGY, Clinical Studies.)
Onchocerciasis. Ivermectin tablets are indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus.
This indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1,427 patients in onchocerciasis-endemic areas of West Africa. The comparative studies used diethylcarbamazine citrate (DEC-C).
NOTE: Ivermectin tablets has no activity against adult Onchocerca volvulus parasites. The adult parasites reside in subcutaneous nodules which are infrequently palpable. Surgical excision of these nodules (nodulectomy) may be considered in the management of patients with onchocerciasis, since this procedure will eliminate the microfilariae-producing adult parasites.
Source: DailyMed label, set id 1fb17bc2-9192-4a0b-a3ee-fda9db035daa, version 3, effective April 9, 2026. NDC 27241-293, one of 11 listings for this product.
Ivermectin, cream
Indications and Usage, quoted from the label by Actavis Pharma, Inc. (ANDA210019). Cross-references to other label sections are left out.
Ivermectin cream, 1% is indicated for the treatment of inflammatory lesions of rosacea.
Source: DailyMed label, set id de9253c3-7d66-47fe-8ad7-8c0d4ee8ebda, version 8, effective May 31, 2025. NDC 0591-4052, one of 7 listings for this product.
Questions
What is ivermectin used for?
The FDA label says: “Ivermectin tablets, USP are indicated for the treatment of the following infections:”
What drug class is ivermectin?
FDA lists ivermectin in the Antiparasitic and Pediculicide established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.